CAPMATINIB (INC280) IN MET Delta EX14-MUTATED ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC): EFFICACY DATA FROM THE PHASE 2 GEOMETRY MONO-1 STUDY

Rebecca S. Heist, Takashi Seto, Ji-Youn Han, Noemi Reguart, Edward B. Garon, Harry J. M. Groen, Daniel S. W. Tan, Toyoaki Hida, Maja de Jonge, Sergey V. Orlov, Egbert F. Smit, Pierre-Jean Souquet, Johan Vansteenkiste, Sylvie Le Mouhaer, Anna Robeva, Maeve Waldron-Lynch, Monica Giovannini, Juergen Wolf

    Research output: Contribution to journalMeeting AbstractAcademic

    Original languageEnglish
    Pages (from-to)56
    Number of pages1
    JournalNeuro-Oncology
    Volume21
    Publication statusPublished - Nov-2019
    Event24th Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology (SNO) / 3rd SNO-SCIDOT Joint Conference on Therapeutic Delivery to the CNS - Phoenix, Azerbaijan
    Duration: 20-Nov-201924-Nov-2019

    Cite this